SHE/300558 (SHE/300558)

Shenzhen Stock Exchange: SHE/300558 · CNY

CN¥40.9

+0.97 (+2.4%)· Recorded snapshot

Market cap	17.3B
Revenue (ttm)	3.9B
Net income (ttm)	467.6M
EPS (ttm)	CN¥1.12
Shares out	423.3M
P/E (trailing)	36.6x
P/E (forward)	26.0x
Dividend	CN¥0.15 (0.37%)
Volume	6,771,586
Beta	0.52

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.9B
Net income (ttm): 467.6M
EPS (ttm): CN¥1.12
P/E (trailing): 36.6x
P/E (forward): 26.0x
Market cap: 17.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E26

P25 n/aP50 n/aP75 n/a

Trailing P/E36.6

P25 n/aP50 n/aP75 n/a

ROE7.3

P25 n/aP50 n/aP75 n/a

ROIC5.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/300558 indicators

Market & fundamental data

Available fields

248

Groups with data

Currency

CNY

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-29
Employees	1,785
Employees change	89
Employees growth	5.25%
Enterprise value	CNY 19.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2003
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE100002DD9
Last earnings date	2026-08-21
Last refreshed	2026-10-28
Market cap	CNY 17.3B
Next earnings date	2026-10-29
Price	CNY 40.87
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	she/300558
Website	https://www.bettapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	87.56x
Average P/E ratio (3Y)	57.6x
Average P/E ratio (5Y)	81.4x
Earnings yield	2.73%
EV/Earnings	41.34x
EV/EBIT	31.69x
EV/EBITDA	16.52x
EV/FCF	72.3x
EV/Sales	5.02x
FCF / EV yield	1.38%
FCF yield	1.55%
Forward P/E	26.03x
Graham number	19.88333
Graham upside	-51.35%
Industry forward P/E	18.72x
Industry P/E	33.27x
Lynch fair value	CNY 5.58
Lynch upside	-86.35%
P/B ratio	2.61x
P/E ratio	36.63x
P/FCF ratio	64.72x
P/OCF ratio	19.69x
P/S ratio	4.49x
Price / tangible book value	4.79x
Price/EBITDA ratio	14.83x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.83%
EBITDA margin	30.28%
Effective tax rate	24.66%
FCF margin	6.94%
Gross margin	77.21%
Operating margin	15.83%
Pretax margin	15.44%
Profit margin	12.13%
Profit per employee	CNY 261,942
Profitable quarters	2
Profitable years	15
Revenue per employee	CNY 2.2M
ROA	3.91%
ROA (5Y)	2.86%
ROCE	7.4%
ROE	7.28%
ROE (5Y)	5.86%
ROIC	5.23%
ROIC (5Y)	6.2%
Tax / revenue	3.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	48.51%
EPS growth (Q)	66.74%
EPS growth (QoQ)	-72.49%
EPS growth 10Y	1.51%
EPS growth 3Y	33.21%
EPS growth 5Y	-7.5%
EPS growth quarters	3
EPS growth years	0
FCF growth	243.82%
Gross profit growth	18.99%
Gross profit growth (Q)	4.26%
Gross profit growth 3Y	12.32%
Gross profit growth 5Y	9.18%
Net income growth	46.79%
Net income growth (Q)	66.34%
Net income growth (QoQ)	-71.93%
Net income growth 3Y	32.94%
Net income growth 5Y	-7.15%
Net income growth quarters	3
Net income growth years	0
OCF growth	5.29%
OCF growth (Q)	0.88%
OCF growth (QoQ)	-43.58%
OCF growth 10Y	8.59%
OCF growth 3Y	17.68%
OCF growth 5Y	11%
Operating income growth	21.6%
Operating income growth (Q)	-3.84%
Operating income growth 3Y	35.89%
Operating income growth 5Y	5.87%
Revenue growth	23.42%
Revenue growth (Q)	15.02%
Revenue growth (QoQ)	-9.98%
Revenue growth 10Y	15.47%
Revenue growth 3Y	16.5%
Revenue growth 5Y	13.2%
Revenue growth quarters	8
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -611.3M
Depreciation and amortization	CNY 556.9M
EBIT	CNY 609.9M
EBITDA	CNY 1.2B
EPS	CNY 1.12
FCF per share	CNY 0.63
Financing cash flow	CNY -164.2M
Free cash flow	CNY 267.3M
Gross profit	CNY 3B
Income taxes	CNY 146.7M
Investing cash flow	CNY -786.5M
Net borrowing	CNY 30.6M
Net cash flow	CNY -72M
Net income	CNY 467.6M
Operating income	CNY 609.9M
Revenue	CNY 3.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.71
Book value per share	CNY 15.75
Debt / EBITDA	2.11
Debt / equity	0.37
Debt / FCF	9.24
Goodwill	CNY 383.7M
Interest coverage	8.27
Long-term assets	CNY 8.6B
Long-term liabilities	CNY 1.6B
Net cash (debt)	CNY -2B
Net cash / market cap	-11.65%
Net debt / EBITDA	1.73
Net debt / equity	0.3
Net debt / FCF	7.54
Piotroski F-Score	7
Property, plant and equipment	CNY 2.9B
Shareholders' equity	CNY 6.6B
Tangible book value	CNY 3.6B
Tangible book value per share	CNY 8.58
Total assets	CNY 10.3B
Total cash	CNY 455.8M
Total debt	CNY 2.5B
Total liabilities	CNY 3.7B
WACC	6.49%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.4
Current assets	CNY 1.7B
Current liabilities	CNY 2.1B
Current ratio	0.85
Inventory turnover	2.52
Net working capital	CNY 412.1M
Quick ratio	0.53
Working capital	CNY -313.7M
Working capital turnover	-10.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.15%
Dividend growth	-24.6%
Dividend growth (3Y)	28.92%
Dividend growth (5Y)	-13.51%
Dividend growth years	2
Dividend payment date	2026-06-09
Dividend payment years	10
Dividend payout frequency	Annual
Dividend per share	CNY 0.15
Dividend yield	0.37%
Ex-dividend date	2026-06-09
FCF payout ratio	23.61%
Last dividend	CNY 0.15
Payout ratio	27.33%
Shareholder yield	1.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 51.82
1D price change	2.43%
1M price change	-15.26%
1M total return	-15.26%
1W price change	-2.3%
1W total return	-2.3%
1Y price change	-28.88%
1Y return CAGR	-28.68%
1Y total return	-28.67%
20-day SMA	CNY 44.63
200-day SMA	CNY 50.60
3M price change	-32.31%
3M total return	-32.31%
3Y price change	-28.98%
3Y return CAGR	-10.46%
3Y total return	-28.21%
50-day SMA	CNY 48.88
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 78.18
52-week high date	2026-07-06
52-week low	CNY 38.20
52-week low date	2026-10-20
5Y price change	-50.88%
5Y return CAGR	-12.94%
5Y total return	-49.99%
6M price change	-17.4%
6M total return	-17.15%
All-time high	CNY 160.66
All-time high date	2020-07-13
All-time low	CNY 23.19
All-time low date	2016-11-07
Average true range (ATR)	CNY 2.27
Average volume	10.6M
Beta (1Y)	0.54
Beta (2Y)	0.4
Beta (5Y)	0.52
Change from 52-week high	-47.72%
Change from 52-week low	6.99%
Change from all-time high	-74.56%
Change from all-time low	76.24%
Change from open	1.89%
Day's gap	0.53%
Dollar volume	CNY 276.8M
High price	CNY 41.75
Low price	CNY 40.11
Monthly RSI	41.51
Open price	CNY 40.11
Position in 52-week range	46.34%
Previous close	CNY 39.90
Price vs 150-day SMA	-21.13%
Price vs 20-day SMA	-8.42%
Price vs 200-day SMA	-19.22%
Price vs 50-day SMA	-16.39%
Relative volume	0.61
RSI	36.7
Sharpe ratio	-0.43
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	-0.15
Sortino ratio	-0.51
Sortino ratio (3Y)	0.22
Sortino ratio (5Y)	-0.1
Volume	6.8M
Weekly RSI	39.26
YTD price change	-12.47%
YTD total return	-12.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	241.1M
Shares change (QoQ)	2.02%
Shares change (YoY)	-1.15%
Shares held by insiders	2.28%
Shares held by institutions	15.28%
Shares outstanding	423.3M

Deeper analysis on SHE/300558

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/300558 report

Is a complete SHE/300558 research report available?

No complete published report is available for she/300558 (SHE/300558) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/300558 (SHE/300558)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300558

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300558 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300558

Frequently asked questions